Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 3, 1999

View Archived Issues

Peptide Therapeutics, PMC Enter $60M Vaccines Deal

New Osteoporosis Research Finds Critical Bone Gene

Objectors Say Public Voice Weighted To Favor GMOs

Genetic Mutations Multiply To 'Incredibly' High Level

Epidauros, Parexel Enter Pharmacogenomics Deal

Biovector Launches IPO To Fund Growing Research

Pharming Reports Producing Transgenic Female Calves

NTB Raises C$3M To Fuel Nervous-System Research

U.K. Boosting Biotech With Four-Year Program

Germany's Chemical Industry Explores Uses Of DNA Chips

Other News To Note

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.